Your search
Results 22 resources
-
Summary. Describes national leadership failures in the Covid-19 response, which we attribute to the inappropriate influence of secondary considerations.
-
Summary. Describes the adverse secondary effects of allowing confidentiality agreements in medical malpractice cases.
-
Summary. Describes hospitals’ practice of double-booking surgeons to maximize revenue.
-
Summary. Discusses developments in the issue of whether to regulate the practice of double-booking surgeons to maximize revenue.
-
Summary. Describes, among other things, the potential for information collected through digital contact tracing apps to be misused by governments.
-
Summary. Describes legal limits on illegal promotional speech by drug company representatives.
-
Summary. Describes, among other things, how elected officials have allowed political considerations to influence them to attack their own health officers during Covid-19.
-
Summary. Reflects on whether physicians’ concerns about liability affect their willingness to offer honest apologies to patients when errors occur, and whether legal protections for these statements are helpful.
-
Summary. Exhorts academic medical centers not to put risk-management and reputational concerns ahead of the need to support clinicians who wish to provide care in epidemic zones.
-
Summary. Describes the effects of publicly disclosing that physicians receive money from drug companies.
-
Summary. Describes how commonly drug companies fail to adhere to obligations to disclose clinical trial results and how commonly they are willing to share clinical trial data. My collaboration with Dr. Miller is a direct result of my Safra fellowship.
-
Summary. Describes how publicly disclosing drug company payments to physicians affects trust.
-
Summary. Explores how liability concerns influence physicians to order tests that patients don’t need.
-
Summary. Describes how commonly drug companies fail to adhere to obligations to disclose clinical trial results. My collaboration with Dr. Miller is a direct result of my Safra fellowship.
-
Summary. Describes how common it is for patients’ primary physician to have taken payments from drug companies.
-
Summary. Describes gaps in the oversight of problematic faculty consulting relationships. This was my Safra project.
-
Summary. Provides recommendations to hospitals dealing with surgeons’ requests to double-book operations.
-
Summary. Investigates factors that lead physicians to be untruthful with patients.